The FDA requires each establishment to register, submit and update a list of every HCT/P where collection, donor screening, donor testing, processing, storage, labeling, packaging, and distribution are performed. These requirements are described in 21 CFR 1271 Subpart B. Establishments must register and submit HCT/P lists using Form FDA 3356 which must be updated annually in December. Electronic registration also is available. Search for a registered HCT/P establishment using FDA's public query.
REGULATORY UPDATE: FDA Issues Draft Guidance to Support CGT Development
November 19, 2024
AABB Accepting Feedback on Cell and Gene Therapy Standards for Pharmacy
November 19, 2024
FDA Approves Direct-to-Brain Gene Therapy for AADC Deficiency
November 14, 2024
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
